Patents by Inventor Rishi Jain

Rishi Jain has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220348933
    Abstract: Provided in this disclosure, in some embodiments, are methods and compositions for treating maple syrup urine disease (MSUD) and other conditions characterized by excessive branched-chain amino acids.
    Type: Application
    Filed: June 19, 2020
    Publication date: November 3, 2022
    Applicants: Ginkgo Bioworks, Inc., Synlogic Operating Company, Inc.
    Inventors: Patrick Boyle, Dylan Alexander Carlin, Rishi Jain, Ryan Putman, Laura Stone, Alex C. Tucker, Kolea Zimmerman
  • Publication number: 20210071206
    Abstract: The invention relates to a method for the preparation of industrially useful strains of yeast Saccharomyces cerevisiae and the strain prepared by the method. In particular the invention relates to the creation of double mutant strains of the yeast that shows high ethanol conversion efficiency and substantially reduced acetic acid and glycerol production during fermentative production of ethanol from a sugar-based feedstock.
    Type: Application
    Filed: November 28, 2018
    Publication date: March 11, 2021
    Inventors: Rishi JAIN, Dheeraj Madhukar MAHAJAN, Sanjay Ratilal MISTRY, Rutuja Shivaji JAGTAP, Megha Shaligram BILAIYA, Rajesh Kumar SINGH, Ghansham Baburao DESHPANDE, Pramod Shankar KUMBHAR
  • Patent number: 7718700
    Abstract: Growth factor binding compounds having a plurality of acyclic isophthalic acid groups attached to a non-peptide organic scaffold and pharmaceutical compositions of the same are disclosed. Methods of administering and using the growth factor binding compounds or the growth factor binding compositions are also taught. These novel growth factor binding compounds are useful for treating angiogenesis, excessive cellular proliferation, tumor growth, and a combination thereof as well as inhibiting growth factor binding to cells and phosphorylation.
    Type: Grant
    Filed: December 18, 2008
    Date of Patent: May 18, 2010
    Assignees: Yale University, University of South Florida
    Inventors: Said M. Sebti, Andrew D. Hamilton, Rishi Jain
  • Publication number: 20090131487
    Abstract: Growth factor binding compounds having a plurality of acyclic isophthalic acid groups attached to a non-peptide organic scaffold and pharmaceutical compositions of the same are disclosed. Methods of administering and using the growth factor binding compounds or the growth factor binding compositions are also taught. These novel growth factor binding compounds are useful for treating angiogenesis, excessive cellular proliferation, tumor growth, and a combination thereof as well as inhibiting growth factor binding to cells and phosphorylation.
    Type: Application
    Filed: December 18, 2008
    Publication date: May 21, 2009
    Inventors: Said M. Sebti, Andrew D. Hamilton, Rishi Jain
  • Patent number: 7482483
    Abstract: Growth factor binding compounds having a plurality of acyclic isophthalic acid groups attached to a non-peptide organic scaffold and pharmaceutical compositions of the same are disclosed. Methods of administering and using the growth factor binding compounds or the growth factor binding compositions are also taught. These novel growth factor binding compounds are useful for treating angiogenesis, excessive cellular proliferation, tumor growth, and a combination thereof as well as inhibiting growth factor binding to cells and phosphorylation.
    Type: Grant
    Filed: January 27, 2005
    Date of Patent: January 27, 2009
    Assignees: University of South Florida, Yale University
    Inventors: Said M. Sebti, Andrew D. Hamilton, Rishi Jain
  • Publication number: 20050197401
    Abstract: Growth factor binding compounds having a plurality of acyclic isophthalic acid groups attached to a non-peptide organic scaffold and pharmaceutical compositions of the same are disclosed. Methods of administering and using the growth factor binding compounds or the growth factor binding compositions are also taught. These novel growth factor binding compounds are useful for treating angiogenesis, excessive cellular proliferation, tumor growth, and a combination thereof as well as inhibiting growth factor binding to cells and phosphorylation.
    Type: Application
    Filed: January 27, 2005
    Publication date: September 8, 2005
    Inventors: Said Sebti, Andrew Hamilton, Rishi Jain